Skip to main content

Peer Review reports

From: LYZ2-SH3b as a novel and efficient enzybiotic against methicillin-resistant Staphylococcus aureus

Original Submission
12 Jan 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
16 Feb 2023 Reviewed Reviewer Report
18 Feb 2023 Reviewed Reviewer Report
26 Feb 2023 Reviewed Reviewer Report
27 Feb 2023 Reviewed Reviewer Report
4 Apr 2023 Author responded Author comments - Amir Savardashtaki
Resubmission - Version 4
4 Apr 2023 Submitted Manuscript version 4
21 May 2023 Author responded Author comments - Amir Savardashtaki
Resubmission - Version 5
21 May 2023 Submitted Manuscript version 5
25 May 2023 Author responded Author comments - Amir Savardashtaki
Resubmission - Version 6
25 May 2023 Submitted Manuscript version 6
30 May 2023 Reviewed Reviewer Report
8 Jun 2023 Reviewed Reviewer Report
9 Jun 2023 Reviewed Reviewer Report
9 Jun 2023 Reviewed Reviewer Report
7 Jul 2023 Author responded Author comments - Amir Savardashtaki
Resubmission - Version 7
7 Jul 2023 Submitted Manuscript version 7
9 Jul 2023 Author responded Author comments - Amir Savardashtaki
Resubmission - Version 8
9 Jul 2023 Submitted Manuscript version 8
14 Jul 2023 Reviewed Reviewer Report
20 Jul 2023 Reviewed Reviewer Report
23 Jul 2023 Reviewed Reviewer Report
1 Aug 2023 Reviewed Reviewer Report
15 Aug 2023 Author responded Author comments - Amir Savardashtaki
Resubmission - Version 9
15 Aug 2023 Submitted Manuscript version 9
26 Aug 2023 Reviewed Reviewer Report
Resubmission - Version 10
Submitted Manuscript version 10
Publishing
4 Sep 2023 Editorially accepted
13 Sep 2023 Article published 10.1186/s12866-023-03002-9

You can find further information about peer review here.

Back to article page